Exciton binding regulation in oxygen-independent tumor photooxidation enables synchronous photoluminescence for cancer theranostics
Overcoming the accuracy-efficiency trade-off in light-driven cancer therapy remains a significant challenge for theranostics. Herein, we report a fullerene-loaded heptazine‒perylene (HP/C60) nanopolymer that enables the oxygen-independent oxidation of intracellular biomolecules via photogenerated hole transfer (+1.53 V vs. NHE). Concurrently, HP/C60 facilitates cancer theranostics through spatiotemporal fluorescence imaging with resistance to photobleaching. By precisely tuning the exciton binding energy through controlled interface-induced charge delocalization, we optimize the ratio of exciton recombination and dissociation pathways, enabling the rational allocation of photoluminescence for high-contrast bioimaging and photooxidation for efficient tumor elimination. A 20-minute red light irradiation of HP/C60 is sufficient to initiate the complete ablation of solid tumors of female mice, with the entire therapeutic process monitored via real-time fluorescence imaging. This work establishes exciton management as a universal design principle to synchronize photooxidation and photoluminescence and supports the development of organic semiconductors for cancer theranostics. Overcoming the accuracy-efficiency trade-off in light-driven cancer therapy is challenging for developing theranostic systems. Here, the authors report a fullerene-loaded heptazine‒perylene nanopolymer that facilitates cancer theranostics through the oxygen-independent oxidation of intracellular biomolecules, and through spatiotemporal fluorescence imaging with resistance to photobleaching.
Authors
- Yongfa Zhu (ORCID: https://orcid.org/0000-0001-8528-509X)
- Qixin Zhou (ORCID: https://orcid.org/0000-0002-9173-2164)
- Yunning Chen (ORCID: https://orcid.org/0000-0001-5871-2834)
- Yan Guo (ORCID: https://orcid.org/0000-0002-8626-0238)
- MeiChi Chong (ORCID: https://orcid.org/0000-0002-4778-5429)
- Yizhou Yan
- Running Cheng
- Meng Wang
- Mo Zhang
Institutions
- City University of Hong Kong (HK)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences (CN)
- University of Hong Kong (HK)
- Tsinghua University (CN)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1038/s41467-026-79452-2
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Beihang University
- Government of Jiangsu Province
- National Natural Science Foundation of China-Yunnan Joint Fund